Preoperative Treatment of Locally Advanced Rectal CancerDeborah Schrag, Harvey J. Mamon, Qian Shi et al.|New England Journal of Medicine|2023Cited by 440
ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaperArvind Dasari, Scott Kopetz, Cathy Eng et al.|Nature Reviews Clinical Oncology|2020Cited by 365
Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048)Ethan Basch, Deborah Schrag, Amylou C. Dueck et al.|Journal of Clinical Oncology|2023Cited by 136
Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD GroupKaitlyn K.H. Goey, Miriam Koopman, Halfdan Sørbye et al.|European Journal of Cancer|2018Cited by 34
Radiation Therapy Quality Assurance Analysis of Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the PancreasLeila T. Tchelebi, Joseph M. Herman, Diana Segovia et al.|International Journal of Radiation Oncology*Biology*Physics|2024Cited by 31